FDA approves new ADHD drug Mydayis for patients 13 and older.

The FDA has approved a new medication called Mydayis for attention deficit hyperactivity disorder (ADHD). Mydayis is a central nervous system stimulant taken once a day in the morning. It is approved for patients 13 years and older. The drug works by helping to improve focus and reduce impulsivity and hyperactivity. Clinical trials showed it can be effective for up to 16 hours, which is longer than many other ADHD medications. However, this long duration also raises the chance of insomnia, especially if taken too late. The approval was based on studies in adults ages 18 to 55 and teens ages 13 to 17. The FDA did not approve Mydayis for children 12 and younger because they had higher levels of the drug in their blood and more side effects like insomnia and decreased appetite. For patients who qualify, Mydayis offers a new once-daily option. But it is important to talk to your doctor about whether this medicine is right for you or your teen. Your doctor can help weigh the benefits against possible side effects and suggest the best treatment plan.